References
- Sharlip ID, Jarow JP, Belker AM, Lipshultz LI, Sigman M, Thomas AJ, et al. Best practice policies for male infertility. Fertil Steril 2002; 77: 873-82. doi: 10.1016/s0015-0282(02)03105-9
- Cooper TG, Noonan E, von Eckardstein S, Auger J, Baker HW, Behre HM, et al. World Health Organization reference values for human semen characteristics. Hum Reprod Update 2010; 16: 231-45. doi: 10.1093/humupd/dmp048
- Desai N, Sharma R, Makker K, Sabanegh E, Agarwal A. Physiologic and pathologic levels of reactive oxygen species in neat semen of infertile men. Fertil Steril 2009; 92: 1626-31. doi: 10.1016/j.fertnstert.2008.08.109
- Rivlin J, Mendel J, Rubinstein S, Etkovitz N, Breitbart H. Role of hydrogen peroxide in sperm capacitation and acrosome reaction. Biol Reprod 2004; 70: 518-22. doi: 10.1095/biolreprod.103.020487
- Agarwal A, Virk G, Ong C, du Plessis SS. Effect of oxidative stress on male reproduction. World J Mens Health 2014; 32: 1-17. doi: 10.5534/wjmh.2014.32.1.1
- Darbandi M, Darbandi S, Agarwal A, Sengupta P, Durairajanayagam D, Henkel R, et al. Reactive oxygen species and male reproductive hormones. Reprod Biol Endocrinol 2018; 16: 87. doi: 10.1186/s12958-018-0406-2
- Gosalvez J, Tvrda E, Agarwal A. Free radical and superoxide reactivity detection in semen quality assessment: past, present, and future. J Assist Reprod Genet 2017; 34: 697-707. doi: 10.1007/s10815-017-0912-8
- Kao SH, Chao HT, Chen HW, Hwang TI, Liao TL, Wei YH. Increase in oxidative stress in human sperm with lower motility. Fertil Steril 2008; 89: 1183-90. doi: 10.1016/j.fertnstert.2007.05.029
- Agarwal A, Ahmad G, Sharma R. Reference values of reactive oxygen species in seminal ejaculates using chemiluminescence assay. J Assist Reprod Genet 2015; 32: 1721-9. doi: 10.1007/s10815-015-0584-1
- Aitken RJ, De Iuliis GN, Finnie JM, Hedges A, McLachlan RI. Analysis of the relationships between oxidative stress, DNA damage and sperm vitality in a patient population: development of diagnostic criteria. Hum Reprod 2010; 25: 2415-26. doi: 10.1093/humrep/deq214
- Verit FF, Verit A, Kocyigit A, Ciftci H, Celik H, Koksal M. No increase in sperm DNA damage and seminal oxidative stress in patients with idiopathic infertility. Arch Gynecol Obstet 2006; 274: 339-44. doi: 10.1007/s00404-006-0172-9
- Aitken RJ, Clarkson JS, Fishel S. Generation of reactive oxygen species, lipid peroxidation, and human sperm function. Biol Reprod 1989; 41: 183-97. doi: 10.1095/biolreprod41.1.183
- Agarwal A, Saleh RA, Bedaiwy MA. Role of reactive oxygen species in the pathophysiology of human reproduction. Fertil Steril 2003; 79: 829-43. doi: 10.1016/s0015-0282(02)04948-8
- Jacobsen R, Bostofte E, Engholm G, Hansen J, Olsen JH, Skakkebaek NE, et al. Risk of testicular cancer in men with abnormal semen characteristics: cohort study. BMJ 2000; 3: 789-92. doi: 10.1136/bmj.321.7264.789
- Raman JD, Nobert CF, Goldstein M. Increased incidence of testicular cancer in men presenting with infertility and abnormal semen analysis. J Urol 2005; 174: 1819-22. doi: 10.1097/01.ju.0000177491.98461.aa
- Sharma RK, Agarwal A. Role of reactive oxygen species in male infertility. Urology 1996; 48: 835-50. doi: 10.1016/s0090-4295(96)00313-5
- Smith R, Vantman D, Ponce J, Escobar J, Lissi E. Total antioxidant capacity of human seminal plasma. Hum Reprod 1996; 11: 1655-60. doi: 10.1093/oxfordjournals.humrep.a019465
- Pahune PP, Choudhari AR, Muley PA. The total antioxidant power of semen and its correlation with the fertility potential of human male subjects. J Clin Diagn Res 2013; 7: 991-5. doi: 10.7860/JCDR/2013/4974.3040
- Sposito C, Camargo M, Tibaldi DS, Barradas V, Cedenho AP, Nichi M, et al. Antioxidant enzyme profile and lipid peroxidation products in semen samples of testicular germ cell tumor patients submitted to orchiectomy. Int Braz J Urol 2017; 43: 644-51. doi: 10.1590/S1677-5538
- World Health Organization. WHO Laboratory manual for the examination and processing of human semen 5th edition. Geneva: WHO Press; 2010.
- Shamsi MB, Imam SN, Dada R. Sperm DNA integrity assays: diagnostic and prognostic challenges and implications in management of infertility. J Assist Reprod Genet 2011; 28: 1073-85. doi: 10.1007/s10815-011-9631-8
- Hammadeh ME, Al-Hasani S, Rosenbaum P, Schmidt W, Fischer Hammadeh C. Reactive oxygen species, total antioxidant concentration of seminal plasma and their effect on sperm parameters and outcome of IVF/ICSI patients. Arch Gynecol Obstet 2008; 277: 515-26. doi: 10.1007/s00404-007-0507-1
- Santi D, Spaggiari G, Simoni M. Sperm DNA fragmentation index as a promising predictive tool for male infertility diagnosis and treatment management – meta-analyses. Reprod Biomed Online 2018; 37: 315-26. doi: 10.1016/j.rbmo.2018.06.023
- Gandini L, Lombardo F, Paoli D, Caponecchia L, Familiari G, Verlengia C, et al. Study of apoptotic DNA fragmentation in human spermatozoa. Hum Reprod 2000; 15: 830-9. doi: 10.1093/humrep/15.4.830
- Piomboni P, Focarelli R, Stendardi A, Ferramosca A, Zara V. The role of mitochondria in energy production for human sperm motility Int J Andro 2012; 35: 109-24. doi: 10.1111/j.1365-2605.2011.01218.x
- Marchetti P, Ballot C, Jouy N, Thomas P, Marchetti C. Influence of mitochondrial membrane potential of spermatozoa on in vitro fertilization outcome. Andrologia 2012; 44: 136-41. doi: 10.1111/j.1439-0272.2010.01117.x
- Malić Vončina S, Golob B, Ihan A, Kopitar AN, Kolbezen M, Zorn B. Sperm DNA fragmentation and mitochondrial membrane potential combined are better for predicting natural conception than standard sperm parameters. Fertil Steril 2016; 105: 637-44. doi: 10.1016/j.fertnstert.2015.11.037
- Imamovic Kumalic S, Pinter B. Review of clinical trials on effects of oral antioxidants on basic semen and other parameters in idiopathic oligoasthenoteratozoospermia. Biomed Res Int 2014; 2014: 426951. doi: 10.1155/2014/426951
- Piomboni P, Gambera L, Serafini F, Campanella G, Morgante G, De Leo V. Sperm quality improvement after natural anti-oxidant treatment of asthenoteratospermic men with leukocytospermia. Asian J Androl 2008; 10: 201-6. doi: 10.1111/j.1745-7262.2008.00356.x
- Safarinejad MR. Effect of pentoxifylline on semen parameters, reproductive hormones, and seminal plasma antioxidant capacity in men with idiopathic infertility: a randomized double-blind placebo-controlled study. Int Urol Nephrol 2011; 43: 315-28. doi: 10.1007/s11255-010-9826-4
- Safarinejad MR, Safarinejad S, Shafiei N, Safarinejad S. Effects of the reduced form of coenzyme Q10 (ubiquinol) on semen parameters in men with idiopathic infertility: a double-blind, placebo controlled, randomized study. J Urol 2012; 188: 526-31. doi: 10.1016/j.juro.2012.03.131
- Alizadeh F, Javadi M, Karami AA, Gholaminejad F, Kavianpour M, Haghighian HK. Curcumin nanomicelle improves semen parameters, oxidative stress, inflammatory biomarkers, and reproductive hormones in infertile men: a randomized clinical trial. Phytother Res 2018; 32: 514-21. doi: 10.1002/ptr.5998
- Banihani SA. Effect of ginger (Zingiber officinale) on semen quality. Andrologia 2019; 51: e13296. doi: 10.1111/and.13296
- Jannatifar R, Parivar K, Roodbari NH, Nasr-Esfahani MH. Effects of N-acetylcysteine supplementation on sperm quality, chromatin integrity and level of oxidative stress in infertile men. Reprod Biol Endocrinol 2019; 17: 24. doi: 10.1186/s12958-019-0468-9
- Lipovac M, Bodner F, Imhof M, Chedraui P. Comparison of the effect of a combination of eight micronutrients versus a standard mono preparation on sperm parameters. Reprod Biol Endocrinol 2016; 4: 84. doi: 10.1186/s12958-016-0219-0
- Tremellen K, Miari G, Froiland D, Thompson J. A randomized control trial examining the effect of an antioxidant (Menevit) on pregnancy outcome during IVF-ICSI treatment. Aust NZ J Obstet Gynaecol 2007; 47: 216-1. doi: 10.1111/j.1479-828X.2007.00723.x
- Ghanem H, Shaeer O, El-Segini A. Combination clomiphene citrate and antioxidant therapy for idiopathic male infertility: a randomized controlled trial. Fertil Steril 2010; 93: 2232-5. doi: 10.1016/j.fertnstert.2009.01.117
- Raigani M, Yaghmaei B, Amirjannti N, Lakpour N, Akhondi MM, Zeraati H, et al. The micronutrient supplements, zinc sulphate and folic acid, did not ameliorate sperm functional parameters in oligoasthenoteratozoospermic men. Andrologia 2014; 46: 956-62. doi: 10.1111/and.12180
- Yamamoto Y, Aizawa K, Mieno M, Karamatsu M, Hirano Y, Furui K, et al. The effects of tomato juice on male infertility. Asia Pac J Clin Nutr 2017; 26: 6571. doi: 10.6133/apjcn.102015.17
- Busetto GM, Agarwal A, Virmani A, Antonini G, Ragonesi G, Del Giudice F, et al. Effect of metabolic and antioxidant supplementation on sperm parameters in oligo-astheno-teratozoospermia, with and without varicocele: a double-blind placebo-controlled study. Andrologia 2018; 50: e12927. doi: 10.1111/and.12927
- Smits RM, Mackenzie-Proctor R, Yazdani A, Stankiewicz MT, Jordan V, Showell MG. Antioxidants for male subfertility. Cochrane Database Syst Rev 2019; 3: CD007411. doi: 10.1002/14651858.CD007411.pub4
- Yuan JP, Peng J, Yin K, Wang JH. Potential health-promoting effects of astaxanthin: a high-value carotenoid mostly from microalgae. Mol Nutr Food Res 2011; 55: 150-65. doi: 10.1002/mnfr.201000414
- Miki W. Biological functions and activities of animal carotenoids. Pure Appl Chem 1991; 63: 141-6. doi: 10.1351/pac199163010141
- Dona G, Kozuh I, Brunati AM, Andrisani A, Ambrosini G, Bonanni G, et al. Effect of astaxanthin on human sperm capacitation. Mar Drugs 2013; 11: 1909-19. doi: 10.3390/md11061909
- Andrisani A, Donà G, Tibaldi E, Brunati AM, Sabbadin C, Armanini D, et al. Astaxanthin improves human sperm capacitation by inducing lyn displacement and activation. Mar Drugs 2015; 13: 5533-51. doi: 10.3390/ md13095533
- Comhaire FH, El Garem Y, Mahmoud A, Eertmans F, Schoonjans F. Combined conventional/antioxidant “Astaxanthin” treatment for male infertility: a double blind, randomized trial. Asian J Androl 2005; 7: 257-62. doi: 10.1111/j.1745-7262.2005.00047.x
- Björndahl L, Barratt CLR, Mortimer D, Jouannet P. ‘How to count sperm properly’: checklist for acceptability of studies based on human semen analysis. Hum Reprod 2016; 31: 227-32. doi: 10.1093/humrep/dev305
- Franco JG Jr, Baruffi RL, Mauri AL, Petersen CG, Oliveira JB, Vagnini L. Significance of large nuclear vacuoles in human spermatozoa: implications for ICSI. Reprod Biomed Online 2008; 17: 42-5. doi: 10.1016/s1472-6483(10)60291-x
- Sergerie M, Laforest G, Bujan L, Bissonnette F, Bleau G. Sperm DNA fragmentation: threshold value in male fertility. Hum Reprod 2005; 20: 3446-51. doi: 10.1093/humrep/dei231
- Armstrong JS, Rajasekaran M, Chamulitrat W, Gatti P, Hellstrom WJ, Sikka SC. Characterization of reactive oxygen species induced effects on human spermatozoa movement and energy metabolism. Free Radic Biol Med 1999; 26: 869-80. doi: 10.1016/s0891-5849(98)00275-5
- Colpi GM, Contalbi GF, Nerva F, Sagone P, Piediferro G. Testicular function following chemo-radiotherapy. Eur J Obstet Gynecol Reprod Biol 2004; 13(Suppl 1): S2-6. doi: 10.1016/j.ejogrb.2003.11.002
- Pont J, Albrecht W. Fertility after chemotherapy for testicular germ cell cancer. Fertil Steril 1997; 68: 1-5. doi: 10.1016/s0015-0282(97)81465-3
- Fossa SD, Aass N, Molne K. Is routine pre-treatment cryopreservation of semen worthwhile in the management of patients with testicular cancer? Br J Urol 1989; 64: 524-9. doi: 10.1111/j.1464-410x.1989.tb05292.x
- Horwich A, Nicholls EJ, Hendry WF. Seminal analysis after orchiectomy in stage I teratoma. Br J Urol 1988; 62: 79-81. doi: 10.1111/j.1464-410x.1988.tb04272.x
- Berthelsen JG. Sperm counts and serum follicle-stimulating hormone levels before and after radiotherapy and chemotherapy in men with testicular germ cell cancer. Fertil Steril 1984; 41: 281-6. doi: 10.1016/s0015-0282(16)47605-3
- Rueffer U, Breuer K, Josting A, Lathan B, Sieber M, Manzke O, et al. Male gonadal dysfunction in patients with Hodgkin’s disease prior to treatment. Ann Oncol 2001; 12: 1307-11. doi: 10.1023/a:1012464703805
- Van der Kaaij MA, Heutte N, Echten AJV, Raemaekers JMM, Carde P, Noordijk EM, et al. Sperm quality before treatment in patients with early stage Hodgkin’s lymphoma enrolled in EORTC-GELA lymphoma group trials. Haematologica 2009; 94: 1691-7. doi: 10.3324/haematol.2009.009696
- Viviani S, Ragni G, Santoro A, Perotti L, Caccamo E, Negretti E, et al. Testicular dysfunction in Hodgkin’s disease before and after treatment. Eur J Cancer 1991; 27: 1389-92. doi: 10.1016/0277-5379(91)90017-8
- Steiner A, Hansen K, Diamond MP, Coutifaris C, Cedars M, Legro R, et al. Antioxidants in the treatment of male factor infertility: results from double blind, multi-center, randomized controlled males, antioxidants, and infertility (MOXI) trial. [abstract O-064]. In: Abstracts of the 34th annual meeting of the European Society of Human Reproduction and Embryology 2018. Hum Reprod 33(Supp 1): i30.
- Donnelly ET, McClure N, Lewis SE. Antioxidant supplementation in vitro does not improve human sperm motility. Fertil Steril 1999; 72: 484-95. doi: 10.1016/s0015-0282(99)00267-8
- Safarinejad MR, Shafiei N, Safarinejad S. A prospective double-blind randomized placebo-controlled study of the effect of saffron (Crocussativus Linn.) on semen parameters and seminal plasma antioxidant capacity in infertile men with idiopathic oligoasthenoteratozoospermia. Phytother Res 2011; 25: 508-16. doi: 10.1002/ptr.3294
- Rafiee B, Morowvat MH, Rahimi-Ghalati N. Comparing the effectiveness of dietary vitamin C and exercise interventions on fertility parameters in normal obese men. Urol J 2016; 13: 2635-9. PMID: 27085565
- Bozhedomov VA, Lipatova NA, Bozhedomova GE, Rokhlikov IM, Shcherbakova EV, Komarina RA. Using L- and acetyl-L-carnintines in combination with clomiphene citrate and antioxidant complex for treating idiopathic male infertility: a prospecitive randomized trial. Urologia 2017; 3: 22-32. doi: 10.18565/urol.2017.3.22-32
- Kirsch I. How expectancies shape experience Washington: American Psychological Association; 1999.
- Bjørkedal E, Flaten MA. Interaction between expectancies and drug effects: an experimental investigation of placebo analgesia with caffeine as an active placebo. Psychopharmacology 2011; 215: 537-48. doi: 10.1007/s00213-011-2233-4
- Benedetti F. Placebo-effects: understanding the mechanisms in health and disease Oxford: Oxford University Press; 2009.
- Ahmadi S, Bashiri R, Ghadiri-Anari A, Nadjarzadeh A. Antioxidant supplements and semen parameters: an evidence based review. Int J Reprod Biomed 2016; 14: 729-36. PMID: 28066832
- Bergmann M, Behre HM, Nieschlag E. Serum FSH and testicular morphology in male infertility. Clin Endocrinol 1994; 40: 133-6. doi: 10.1111/j.1365-2265.1994.tb02455.x
- Kumar R, Saxena V, Shamsi MB, Venkatesh S, Dada R. Herbo-mineral supplementation in men with idiopathic oligoasthenoteratospermia: a double blind randomized placebo- controlled trial. Indian J Urol 2011; 27: 357-62. doi: 10.4103/0970-1591.85440
- Nadjarzadeh A, Shidfar F, Amirjannati N, Vafa MR, Motevalian SA, Gohari MR, et al. Effect of coenzyme Q10 supplementation on antioxidant enzymes activity and oxidative stress of seminal plasma: a double-blind randomised clinical trial. Andrologia 2014; 46: 177-83. doi: 10.1111/and.12062
- Sandercock P. Negative results: why do they need to be published? Int J Stroke 2012; 7: 32-33. doi: 10.1111/j.1747-4949.2011.00723.x
- Mlinarić A, Horvat M, Šupak Smolčić V. Dealing with the positive publication bias: why you should really publish your negative results. Biochem Med 2017; 27: 030201. doi: 10.11613/BM.2017.030201
- Hart B, Duke D, Lundh A, Bero L. Effect of reporting bias on meta-analyses of drug trials: reanalysis of meta-analyses. BMJ 2012; 344: d7202. doi: 10.1136/bmj.d7202